8月以来,以泰国为代表的周边国家纷纷爆发禽流感,且出现了向人类传播的迹象。由于“达菲”价格相对昂贵,作为二线用药的金刚烷类产品以及兽用疫苗销售预期良好,各国政府可能大量采购,医药行业将成为下半年市场关注的一大焦点。 Since August, bird flu has been reported in neighboring countries, including Thailand, and signs of transmission to humans have emerged. Due to the relative high cost of “Tamiflu”, sales of adrenaline and veterinary vaccines as second-line drugs are expected to be good, and various governments may purchase in large quantities. The pharmaceutical industry will become a major focus of the market in the second half of the year.